img

Global Meningitis Vaccine Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Meningitis Vaccine Market Insights, Forecast to 2034

Global Meningitis Vaccine market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Meningitis Vaccine industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Meningitis Vaccine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Meningitis Vaccine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


GlaxoSmithKline
Baxter International
Sanofi Pasteur
Merck
Novartis
Pfizer
Hualan
Zhejiang Tianyuan
Beijing Tiantan Biological
Segment by Type
Meningitis A+C
Meningitis ACWY135
Meningitis B

Segment by Application


Medical Care
Hospital

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Meningitis Vaccine plant distribution, commercial date of Meningitis Vaccine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Meningitis Vaccine introduction, etc. Meningitis Vaccine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Meningitis Vaccine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Meningitis Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Meningitis Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Meningitis A+C
1.2.3 Meningitis ACWY135
1.2.4 Meningitis B
1.3 Market by Application
1.3.1 Global Meningitis Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Medical Care
1.3.3 Hospital
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Meningitis Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Meningitis Vaccine Revenue by Region
2.2.1 Global Meningitis Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Meningitis Vaccine Revenue by Region (2018-2024)
2.2.3 Global Meningitis Vaccine Revenue by Region (2024-2029)
2.2.4 Global Meningitis Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Meningitis Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Meningitis Vaccine Sales by Region
2.4.1 Global Meningitis Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Meningitis Vaccine Sales by Region (2018-2024)
2.4.3 Global Meningitis Vaccine Sales by Region (2024-2029)
2.4.4 Global Meningitis Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Meningitis Vaccine Sales by Manufacturers
3.1.1 Global Meningitis Vaccine Sales by Manufacturers (2018-2024)
3.1.2 Global Meningitis Vaccine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Meningitis Vaccine in 2022
3.2 Global Meningitis Vaccine Revenue by Manufacturers
3.2.1 Global Meningitis Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Meningitis Vaccine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Meningitis Vaccine Revenue in 2022
3.3 Global Key Players of Meningitis Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Meningitis Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Meningitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Meningitis Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Meningitis Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Meningitis Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Meningitis Vaccine Sales by Type
4.1.1 Global Meningitis Vaccine Historical Sales by Type (2018-2024)
4.1.2 Global Meningitis Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Meningitis Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Meningitis Vaccine Revenue by Type
4.2.1 Global Meningitis Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Meningitis Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Meningitis Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Meningitis Vaccine Price by Type
4.3.1 Global Meningitis Vaccine Price by Type (2018-2024)
4.3.2 Global Meningitis Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Meningitis Vaccine Sales by Application
5.1.1 Global Meningitis Vaccine Historical Sales by Application (2018-2024)
5.1.2 Global Meningitis Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Meningitis Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Meningitis Vaccine Revenue by Application
5.2.1 Global Meningitis Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Meningitis Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Meningitis Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Meningitis Vaccine Price by Application
5.3.1 Global Meningitis Vaccine Price by Application (2018-2024)
5.3.2 Global Meningitis Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Meningitis Vaccine Market Size by Type
6.1.1 US & Canada Meningitis Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Meningitis Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Meningitis Vaccine Market Size by Application
6.2.1 US & Canada Meningitis Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Meningitis Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Meningitis Vaccine Market Size by Country
6.3.1 US & Canada Meningitis Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Meningitis Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Meningitis Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Meningitis Vaccine Market Size by Type
7.1.1 Europe Meningitis Vaccine Sales by Type (2018-2029)
7.1.2 Europe Meningitis Vaccine Revenue by Type (2018-2029)
7.2 Europe Meningitis Vaccine Market Size by Application
7.2.1 Europe Meningitis Vaccine Sales by Application (2018-2029)
7.2.2 Europe Meningitis Vaccine Revenue by Application (2018-2029)
7.3 Europe Meningitis Vaccine Market Size by Country
7.3.1 Europe Meningitis Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Meningitis Vaccine Sales by Country (2018-2029)
7.3.3 Europe Meningitis Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Meningitis Vaccine Market Size
8.1.1 China Meningitis Vaccine Sales (2018-2029)
8.1.2 China Meningitis Vaccine Revenue (2018-2029)
8.2 China Meningitis Vaccine Market Size by Application
8.2.1 China Meningitis Vaccine Sales by Application (2018-2029)
8.2.2 China Meningitis Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Meningitis Vaccine Market Size by Type
9.1.1 Asia Meningitis Vaccine Sales by Type (2018-2029)
9.1.2 Asia Meningitis Vaccine Revenue by Type (2018-2029)
9.2 Asia Meningitis Vaccine Market Size by Application
9.2.1 Asia Meningitis Vaccine Sales by Application (2018-2029)
9.2.2 Asia Meningitis Vaccine Revenue by Application (2018-2029)
9.3 Asia Meningitis Vaccine Sales by Region
9.3.1 Asia Meningitis Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Meningitis Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Meningitis Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Meningitis Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Meningitis Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Meningitis Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Meningitis Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Meningitis Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Meningitis Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Meningitis Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Meningitis Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Meningitis Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Meningitis Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 GlaxoSmithKline Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline Recent Developments
11.2 Baxter International
11.2.1 Baxter International Company Information
11.2.2 Baxter International Overview
11.2.3 Baxter International Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Baxter International Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Baxter International Recent Developments
11.3 Sanofi Pasteur
11.3.1 Sanofi Pasteur Company Information
11.3.2 Sanofi Pasteur Overview
11.3.3 Sanofi Pasteur Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Sanofi Pasteur Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Pasteur Recent Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck Overview
11.4.3 Merck Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Merck Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck Recent Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Overview
11.5.3 Novartis Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Novartis Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novartis Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Pfizer Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 Hualan
11.7.1 Hualan Company Information
11.7.2 Hualan Overview
11.7.3 Hualan Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Hualan Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hualan Recent Developments
11.8 Zhejiang Tianyuan
11.8.1 Zhejiang Tianyuan Company Information
11.8.2 Zhejiang Tianyuan Overview
11.8.3 Zhejiang Tianyuan Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Zhejiang Tianyuan Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Zhejiang Tianyuan Recent Developments
11.9 Beijing Tiantan Biological
11.9.1 Beijing Tiantan Biological Company Information
11.9.2 Beijing Tiantan Biological Overview
11.9.3 Beijing Tiantan Biological Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Beijing Tiantan Biological Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Beijing Tiantan Biological Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Meningitis Vaccine Industry Chain Analysis
12.2 Meningitis Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Meningitis Vaccine Production Mode & Process
12.4 Meningitis Vaccine Sales and Marketing
12.4.1 Meningitis Vaccine Sales Channels
12.4.2 Meningitis Vaccine Distributors
12.5 Meningitis Vaccine Customers
13 Market Dynamics
13.1 Meningitis Vaccine Industry Trends
13.2 Meningitis Vaccine Market Drivers
13.3 Meningitis Vaccine Market Challenges
13.4 Meningitis Vaccine Market Restraints
14 Key Findings in The Global Meningitis Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Meningitis Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Meningitis A+C
Table 3. Major Manufacturers of Meningitis ACWY135
Table 4. Major Manufacturers of Meningitis B
Table 5. Global Meningitis Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Meningitis Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Meningitis Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Meningitis Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Meningitis Vaccine Revenue Market Share by Region (2018-2024)
Table 10. Global Meningitis Vaccine Revenue Market Share by Region (2024-2029)
Table 11. Global Meningitis Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Meningitis Vaccine Sales by Region (2018-2024) & (K MT)
Table 13. Global Meningitis Vaccine Sales by Region (2024-2029) & (K MT)
Table 14. Global Meningitis Vaccine Sales Market Share by Region (2018-2024)
Table 15. Global Meningitis Vaccine Sales Market Share by Region (2024-2029)
Table 16. Global Meningitis Vaccine Sales by Manufacturers (2018-2024) & (K MT)
Table 17. Global Meningitis Vaccine Sales Share by Manufacturers (2018-2024)
Table 18. Global Meningitis Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Meningitis Vaccine Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Meningitis Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Meningitis Vaccine Price by Manufacturers 2018-2024 (USD/MT)
Table 22. Global Meningitis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Meningitis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningitis Vaccine as of 2022)
Table 24. Global Key Manufacturers of Meningitis Vaccine, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Meningitis Vaccine, Product Offered and Application
Table 26. Global Key Manufacturers of Meningitis Vaccine, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Meningitis Vaccine Sales by Type (2018-2024) & (K MT)
Table 29. Global Meningitis Vaccine Sales by Type (2024-2029) & (K MT)
Table 30. Global Meningitis Vaccine Sales Share by Type (2018-2024)
Table 31. Global Meningitis Vaccine Sales Share by Type (2024-2029)
Table 32. Global Meningitis Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Meningitis Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Meningitis Vaccine Revenue Share by Type (2018-2024)
Table 35. Global Meningitis Vaccine Revenue Share by Type (2024-2029)
Table 36. Meningitis Vaccine Price by Type (2018-2024) & (USD/MT)
Table 37. Global Meningitis Vaccine Price Forecast by Type (2024-2029) & (USD/MT)
Table 38. Global Meningitis Vaccine Sales by Application (2018-2024) & (K MT)
Table 39. Global Meningitis Vaccine Sales by Application (2024-2029) & (K MT)
Table 40. Global Meningitis Vaccine Sales Share by Application (2018-2024)
Table 41. Global Meningitis Vaccine Sales Share by Application (2024-2029)
Table 42. Global Meningitis Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Meningitis Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Meningitis Vaccine Revenue Share by Application (2018-2024)
Table 45. Global Meningitis Vaccine Revenue Share by Application (2024-2029)
Table 46. Meningitis Vaccine Price by Application (2018-2024) & (USD/MT)
Table 47. Global Meningitis Vaccine Price Forecast by Application (2024-2029) & (USD/MT)
Table 48. US & Canada Meningitis Vaccine Sales by Type (2018-2024) & (K MT)
Table 49. US & Canada Meningitis Vaccine Sales by Type (2024-2029) & (K MT)
Table 50. US & Canada Meningitis Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Meningitis Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Meningitis Vaccine Sales by Application (2018-2024) & (K MT)
Table 53. US & Canada Meningitis Vaccine Sales by Application (2024-2029) & (K MT)
Table 54. US & Canada Meningitis Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Meningitis Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Meningitis Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Meningitis Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Meningitis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Meningitis Vaccine Sales by Country (2018-2024) & (K MT)
Table 60. US & Canada Meningitis Vaccine Sales by Country (2024-2029) & (K MT)
Table 61. Europe Meningitis Vaccine Sales by Type (2018-2024) & (K MT)
Table 62. Europe Meningitis Vaccine Sales by Type (2024-2029) & (K MT)
Table 63. Europe Meningitis Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Meningitis Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Meningitis Vaccine Sales by Application (2018-2024) & (K MT)
Table 66. Europe Meningitis Vaccine Sales by Application (2024-2029) & (K MT)
Table 67. Europe Meningitis Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Meningitis Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Meningitis Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Meningitis Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Meningitis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Meningitis Vaccine Sales by Country (2018-2024) & (K MT)
Table 73. Europe Meningitis Vaccine Sales by Country (2024-2029) & (K MT)
Table 74. China Meningitis Vaccine Sales by Type (2018-2024) & (K MT)
Table 75. China Meningitis Vaccine Sales by Type (2024-2029) & (K MT)
Table 76. China Meningitis Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Meningitis Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Meningitis Vaccine Sales by Application (2018-2024) & (K MT)
Table 79. China Meningitis Vaccine Sales by Application (2024-2029) & (K MT)
Table 80. China Meningitis Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Meningitis Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Meningitis Vaccine Sales by Type (2018-2024) & (K MT)
Table 83. Asia Meningitis Vaccine Sales by Type (2024-2029) & (K MT)
Table 84. Asia Meningitis Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Meningitis Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Meningitis Vaccine Sales by Application (2018-2024) & (K MT)
Table 87. Asia Meningitis Vaccine Sales by Application (2024-2029) & (K MT)
Table 88. Asia Meningitis Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Meningitis Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Meningitis Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Meningitis Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Meningitis Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Meningitis Vaccine Sales by Region (2018-2024) & (K MT)
Table 94. Asia Meningitis Vaccine Sales by Region (2024-2029) & (K MT)
Table 95. Middle East, Africa and Latin America Meningitis Vaccine Sales by Type (2018-2024) & (K MT)
Table 96. Middle East, Africa and Latin America Meningitis Vaccine Sales by Type (2024-2029) & (K MT)
Table 97. Middle East, Africa and Latin America Meningitis Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Meningitis Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Meningitis Vaccine Sales by Application (2018-2024) & (K MT)
Table 100. Middle East, Africa and Latin America Meningitis Vaccine Sales by Application (2024-2029) & (K MT)
Table 101. Middle East, Africa and Latin America Meningitis Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Meningitis Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Meningitis Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Meningitis Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Meningitis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Meningitis Vaccine Sales by Country (2018-2024) & (K MT)
Table 107. Middle East, Africa and Latin America Meningitis Vaccine Sales by Country (2024-2029) & (K MT)
Table 108. GlaxoSmithKline Company Information
Table 109. GlaxoSmithKline Description and Major Businesses
Table 110. GlaxoSmithKline Meningitis Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 111. GlaxoSmithKline Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. GlaxoSmithKline Recent Developments
Table 113. Baxter International Company Information
Table 114. Baxter International Description and Major Businesses
Table 115. Baxter International Meningitis Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 116. Baxter International Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Baxter International Recent Developments
Table 118. Sanofi Pasteur Company Information
Table 119. Sanofi Pasteur Description and Major Businesses
Table 120. Sanofi Pasteur Meningitis Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 121. Sanofi Pasteur Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Sanofi Pasteur Recent Developments
Table 123. Merck Company Information
Table 124. Merck Description and Major Businesses
Table 125. Merck Meningitis Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 126. Merck Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Merck Recent Developments
Table 128. Novartis Company Information
Table 129. Novartis Description and Major Businesses
Table 130. Novartis Meningitis Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 131. Novartis Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Novartis Recent Developments
Table 133. Pfizer Company Information
Table 134. Pfizer Description and Major Businesses
Table 135. Pfizer Meningitis Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 136. Pfizer Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Pfizer Recent Developments
Table 138. Hualan Company Information
Table 139. Hualan Description and Major Businesses
Table 140. Hualan Meningitis Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 141. Hualan Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Hualan Recent Developments
Table 143. Zhejiang Tianyuan Company Information
Table 144. Zhejiang Tianyuan Description and Major Businesses
Table 145. Zhejiang Tianyuan Meningitis Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 146. Zhejiang Tianyuan Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Zhejiang Tianyuan Recent Developments
Table 148. Beijing Tiantan Biological Company Information
Table 149. Beijing Tiantan Biological Description and Major Businesses
Table 150. Beijing Tiantan Biological Meningitis Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 151. Beijing Tiantan Biological Meningitis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Beijing Tiantan Biological Recent Developments
Table 153. Key Raw Materials Lists
Table 154. Raw Materials Key Suppliers Lists
Table 155. Meningitis Vaccine Distributors List
Table 156. Meningitis Vaccine Customers List
Table 157. Meningitis Vaccine Market Trends
Table 158. Meningitis Vaccine Market Drivers
Table 159. Meningitis Vaccine Market Challenges
Table 160. Meningitis Vaccine Market Restraints
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Meningitis Vaccine Product Picture
Figure 2. Global Meningitis Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Meningitis Vaccine Market Share by Type in 2022 & 2029
Figure 4. Meningitis A+C Product Picture
Figure 5. Meningitis ACWY135 Product Picture
Figure 6. Meningitis B Product Picture
Figure 7. Global Meningitis Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Meningitis Vaccine Market Share by Application in 2022 & 2029
Figure 9. Medical Care
Figure 10. Hospital
Figure 11. Meningitis Vaccine Report Years Considered
Figure 12. Global Meningitis Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Meningitis Vaccine Revenue 2018-2029 (US$ Million)
Figure 14. Global Meningitis Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Meningitis Vaccine Revenue Market Share by Region (2018-2029)
Figure 16. Global Meningitis Vaccine Sales 2018-2029 ((K MT)
Figure 17. Global Meningitis Vaccine Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Meningitis Vaccine Sales YoY (2018-2029) & (K MT)
Figure 19. US & Canada Meningitis Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Meningitis Vaccine Sales YoY (2018-2029) & (K MT)
Figure 21. Europe Meningitis Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Meningitis Vaccine Sales YoY (2018-2029) & (K MT)
Figure 23. China Meningitis Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Meningitis Vaccine Sales YoY (2018-2029) & (K MT)
Figure 25. Asia (excluding China) Meningitis Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Meningitis Vaccine Sales YoY (2018-2029) & (K MT)
Figure 27. Middle East, Africa and Latin America Meningitis Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Meningitis Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Meningitis Vaccine in the World: Market Share by Meningitis Vaccine Revenue in 2022
Figure 30. Global Meningitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Meningitis Vaccine Sales Market Share by Type (2018-2029)
Figure 32. Global Meningitis Vaccine Revenue Market Share by Type (2018-2029)
Figure 33. Global Meningitis Vaccine Sales Market Share by Application (2018-2029)
Figure 34. Global Meningitis Vaccine Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Meningitis Vaccine Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Meningitis Vaccine Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Meningitis Vaccine Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Meningitis Vaccine Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Meningitis Vaccine Revenue Share by Country (2018-2029)
Figure 40. US & Canada Meningitis Vaccine Sales Share by Country (2018-2029)
Figure 41. U.S. Meningitis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Meningitis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Meningitis Vaccine Sales Market Share by Type (2018-2029)
Figure 44. Europe Meningitis Vaccine Revenue Market Share by Type (2018-2029)
Figure 45. Europe Meningitis Vaccine Sales Market Share by Application (2018-2029)
Figure 46. Europe Meningitis Vaccine Revenue Market Share by Application (2018-2029)
Figure 47. Europe Meningitis Vaccine Revenue Share by Country (2018-2029)
Figure 48. Europe Meningitis Vaccine Sales Share by Country (2018-2029)
Figure 49. Germany Meningitis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 50. France Meningitis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Meningitis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Meningitis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Meningitis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 54. China Meningitis Vaccine Sales Market Share by Type (2018-2029)
Figure 55. China Meningitis Vaccine Revenue Market Share by Type (2018-2029)
Figure 56. China Meningitis Vaccine Sales Market Share by Application (2018-2029)
Figure 57. China Meningitis Vaccine Revenue Market Share by Application (2018-2029)
Figure 58. Asia Meningitis Vaccine Sales Market Share by Type (2018-2029)
Figure 59. Asia Meningitis Vaccine Revenue Market Share by Type (2018-2029)
Figure 60. Asia Meningitis Vaccine Sales Market Share by Application (2018-2029)
Figure 61. Asia Meningitis Vaccine Revenue Market Share by Application (2018-2029)
Figure 62. Asia Meningitis Vaccine Revenue Share by Region (2018-2029)
Figure 63. Asia Meningitis Vaccine Sales Share by Region (2018-2029)
Figure 64. Japan Meningitis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Meningitis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Meningitis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Meningitis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. India Meningitis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Meningitis Vaccine Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Meningitis Vaccine Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Meningitis Vaccine Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Meningitis Vaccine Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Meningitis Vaccine Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Meningitis Vaccine Sales Share by Country (2018-2029)
Figure 75. Brazil Meningitis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Meningitis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Meningitis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Meningitis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Meningitis Vaccine Revenue (2018-2029) & (US$ Million)
Figure 80. Meningitis Vaccine Value Chain
Figure 81. Meningitis Vaccine Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries